We discover and develop innovative medicines for tomorrow, while helping people live better today. For Allergan Healthcare legacy providers, patients and caregivers, submit your inquiry here. We're also pleased to have the opportunity to hear from you on these social channels, but remember that we work in a highly regulated industry with unique legal considerations. Before participating, read and follow our established community guidelines for each channel.
Links that take you outside AbbVie websites worldwide are not under the control of AbbVie, and AbbVie is not responsible for the content of such sites or any other links from such site. AbbVie provides these links to you only as a convenience and the inclusion of any link does not imply approval of the linked site by AbbVie. Allergan plc is an American pharmaceutical company based in Ireland that purchases, develops, manufactures and markets brand-name medicines and medical devices in the areas of medical aesthetics, eye care, central nervous system and gastroenterology. The company is the creator of Botox.
It became a public company through an initial public offering. In 1977, Allergan announced plans to build a factory in Westport, Ireland. In 1991, Allergan acquired the company Oculinum, which manufactured products for ocular muscle disorders. After the acquisition, the product was renamed Botox.
In 1996, Allergan received FDA approval for Alphagan ophthalmic solution for open-angle glaucoma and ocular hypertension. In 1998, Allergan created The Allergan Foundation, a private charitable foundation based in the United States. Auden Mckenzie Holdings Limited (Acq 201 Furiex Pharmaceuticals Inc (Acq 201 Procter %26 Gamble (Prescription Drug Div, Acq 200 Specifar Pharmaceuticals S, A.